家长对9-10岁儿童HPV疫苗接种意愿的相关因素:基于既往疫苗决策经验与选择的分组分析
2024年10月对美国9-10岁未接种HPV疫苗儿童的家长进行全国在线调查,按有无已接种或未接种HPV疫苗的年长子女分为三组,用多变量线性回归分析接种意愿相关因素。总体接种意愿均分为3.21,遵循医疗提供者建议及认为尽早接种有益者意愿更高。将常规接种年龄提前至9-10岁未必提高总体接种率,但扩展至9-12岁可创造重复推荐与个性化沟通机会。
要点
- 家长对9-10岁HPV疫苗接种的总体意愿均分为3.21(满分未报告)。
- 有已接种年长子女的家长感知获益最高、障碍最低。
- 遵循医疗提供者年龄建议及认为尽早接种有益者接种意愿更高。
核心结论
- 将常规HPV疫苗接种年龄提前至9-10岁未必提高总体接种率,但扩展至9-12岁可创造重复提供者推荐与个性化沟通的机会。
- 遵循医疗提供者接种年龄建议及认为尽早接种有益的家长对9-10岁接种HPV疫苗的意愿更高。
研究设计与样本
- 2024年10月通过美国研究小组招募9-10岁未接种HPV疫苗儿童的家长进行全国在线调查。
- 最终样本2272名家长,分为无年长子女组(41%)、有已接种HPV疫苗年长子女组(35%)、有未接种HPV疫苗年长子女组(24%)。
- 采用多变量线性回归模型分析各组中与9-10岁HPV疫苗接种意愿相关的因素。
主要发现
- 总体9-10岁接种意愿均分为3.21。
- 有已接种HPV疫苗年长子女的家长对9-10岁接种的感知获益最高、感知障碍最低。
- 所有组中,遵循医疗提供者接种年龄建议者及认为尽早接种有益者,9-10岁接种意愿更高。
临床怎么用
- 医疗提供者可针对家长既往疫苗决策经验进行个性化沟通,强调尽早接种的获益并明确遵循提供者年龄建议。
- 政策制定可考虑将常规接种年龄范围扩展至9-12岁,以增加重复推荐和沟通的机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: This study aimed to understand how a routine HPV vaccine recommendation at age 9-10 rather than 11-12 may influence parents' vaccine intentions, including parents with varied experience/prior choices related to HPV vaccine decision-making. Additionally, we sought to identify factors (older child vaccination status, items informed by the Theory of Planned Behavior, and socio-demographic/health characteristics) associated with vaccine intention for ages 9-10. METHODS: A national online survey of parents of children ages 9-10 who had not yet received the HPV vaccine was conducted in October 2024. Participants were recruited though a US research panel and assigned to one of three groups: (Group 1) parents without an older child; (Group 2) parents with an HPV-vaccinated older child; or (Group 3) parents with a non-HPV-vaccinated older child. Multivariable linear regression models identified factors associated with HPV vaccine intention at ages 9-10 for each group. RESULTS: The final sample included 2272 parents (Group 1: 41%, Group 2: 35%, Group 3: 24%). Overall mean score for intention to vaccinate at ages 9-10 was 3.21. Group 2 parents reported the highest perceived benefits and lowest perceived barriers for vaccinating at ages 9-10. Across all groups, those who indicated they follow health care provider recommendations for age of vaccination and those who perceive a benefit to vaccinating as early as possible had greater intentions to vaccinate at ages 9-10. CONCLUSION: These findings may help to inform health policy related to HPV vaccination and provider communication strategies. Moving the age of routine vaccination to ages 9-10 may not increase overall vaccination rates, but expansion of the age range (9-12) may create opportunities for repetitive provider recommendation and communication strategies that are personalized based on the parents' prior vaccine decision making.
引用
- Fontenot HB, Liebermann EJ, Thompson EL, et al. Factors associated with intention to obtain HPV vaccination at ages 9-10 among parents with varied prior vaccine decision making experiences and choices. Vaccine. 2026. PMID: 42134134. doi:10.1016/j.vaccine.2026.128698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。